GU Cancers Symp. 2014: Press Releases

MDxHealth’s ConfirmMDx genes identify aggressive prostate cancer - data presented at the 2014 Genitourinary Cancers Symposium January 31, 2014

Dendreon announces presentation of PROVENGE® (sipuleucel-T) data at the 2014 Genitourinary Cancer Symposium (ASCO GU) January 30, 2014

Myriad's Prolaris® test significantly modifies treatment decisions for patients with prostate cancer January 29, 2014

Symposium highlights latest research advances in GU cancers January 28, 2014

Myriad Genetics to present five clinical studies at 2014 ASCO GU Cancer Symposium January 23, 2014

Embargoed presscast on January 28 to feature key research advances in genitourinary cancers, embargoed press release now available January 23, 2014